Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986677019> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W1986677019 endingPage "791" @default.
- W1986677019 startingPage "790" @default.
- W1986677019 abstract "Colchicine is effective for the treatment of acute pericarditis and first recurrences. However, conclusive data are lacking for the efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis.We did this multicentre, double-blind trial at four general hospitals in northern Italy. Adult patients with multiple recurrences of pericarditis (≥two) were randomly assigned (1:1) to placebo or colchicine (0·5 mg twice daily for 6 months for patients weighing more than 70 kg or 0·5 mg once daily for patients weighing 70 kg or less) in addition to conventional anti-inflammatory treatment with aspirin, ibuprofen, or indometacin. Permuted block randomisation (size four) was done with a central computer-based automated sequence. Patients and all investigators were masked to treatment allocation. The primary outcome was recurrent pericarditis in the intention-to-treat population. This trial is registered with ClinicalTrials.gov, number NCT00235079.240 patients were enrolled and 120 were assigned to each group. The proportion of patients who had recurrent pericarditis was 26 (21·6%) of 120 in the colchicine group and 51 (42·5%) of 120 in the placebo group (relative risk 0·49; 95% CI 0·24–0·65; p=0·0009; number needed to treat 5). Adverse effects and discontinuation of study drug occurred in much the same proportions in each group. The most common adverse events were gastrointestinal intolerance (nine patients in the colchicine group vs nine in the placebo group) and hepatotoxicity (three vs one). No serious adverse events were reported.Colchicine added to conventional anti-inflammatory treatment significantly reduced the rate of subsequent recurrences of pericarditis in patients with multiple recurrences. Taken together with results from other randomised controlled trials, these findings suggest that colchicine should be probably regarded as a first-line treatment for either acute or recurrent pericarditis in the absence of contraindications or specific indications.Azienda Sanitaria 3 of Torino (now ASLTO2)." @default.
- W1986677019 created "2016-06-24" @default.
- W1986677019 creator A5012244244 @default.
- W1986677019 creator A5020652190 @default.
- W1986677019 creator A5022746540 @default.
- W1986677019 creator A5080945678 @default.
- W1986677019 date "1995-10-01" @default.
- W1986677019 modified "2023-09-30" @default.
- W1986677019 title "Une électrophorèse renversante" @default.
- W1986677019 doi "https://doi.org/10.1016/0248-8663(96)80791-0" @default.
- W1986677019 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8525162" @default.
- W1986677019 hasPublicationYear "1995" @default.
- W1986677019 type Work @default.
- W1986677019 sameAs 1986677019 @default.
- W1986677019 citedByCount "1" @default.
- W1986677019 crossrefType "journal-article" @default.
- W1986677019 hasAuthorship W1986677019A5012244244 @default.
- W1986677019 hasAuthorship W1986677019A5020652190 @default.
- W1986677019 hasAuthorship W1986677019A5022746540 @default.
- W1986677019 hasAuthorship W1986677019A5080945678 @default.
- W1986677019 hasConcept C126322002 @default.
- W1986677019 hasConcept C141071460 @default.
- W1986677019 hasConcept C142724271 @default.
- W1986677019 hasConcept C197934379 @default.
- W1986677019 hasConcept C204787440 @default.
- W1986677019 hasConcept C27081682 @default.
- W1986677019 hasConcept C2776636253 @default.
- W1986677019 hasConcept C2778715236 @default.
- W1986677019 hasConcept C2781001862 @default.
- W1986677019 hasConcept C2908647359 @default.
- W1986677019 hasConcept C71924100 @default.
- W1986677019 hasConcept C90924648 @default.
- W1986677019 hasConcept C99454951 @default.
- W1986677019 hasConceptScore W1986677019C126322002 @default.
- W1986677019 hasConceptScore W1986677019C141071460 @default.
- W1986677019 hasConceptScore W1986677019C142724271 @default.
- W1986677019 hasConceptScore W1986677019C197934379 @default.
- W1986677019 hasConceptScore W1986677019C204787440 @default.
- W1986677019 hasConceptScore W1986677019C27081682 @default.
- W1986677019 hasConceptScore W1986677019C2776636253 @default.
- W1986677019 hasConceptScore W1986677019C2778715236 @default.
- W1986677019 hasConceptScore W1986677019C2781001862 @default.
- W1986677019 hasConceptScore W1986677019C2908647359 @default.
- W1986677019 hasConceptScore W1986677019C71924100 @default.
- W1986677019 hasConceptScore W1986677019C90924648 @default.
- W1986677019 hasConceptScore W1986677019C99454951 @default.
- W1986677019 hasIssue "10" @default.
- W1986677019 hasLocation W19866770191 @default.
- W1986677019 hasLocation W19866770192 @default.
- W1986677019 hasOpenAccess W1986677019 @default.
- W1986677019 hasPrimaryLocation W19866770191 @default.
- W1986677019 hasRelatedWork W1977915442 @default.
- W1986677019 hasRelatedWork W1986043820 @default.
- W1986677019 hasRelatedWork W2029872562 @default.
- W1986677019 hasRelatedWork W2043656078 @default.
- W1986677019 hasRelatedWork W2096599976 @default.
- W1986677019 hasRelatedWork W2101273511 @default.
- W1986677019 hasRelatedWork W2509102166 @default.
- W1986677019 hasRelatedWork W3159907377 @default.
- W1986677019 hasRelatedWork W4230537958 @default.
- W1986677019 hasRelatedWork W4306722605 @default.
- W1986677019 hasVolume "16" @default.
- W1986677019 isParatext "false" @default.
- W1986677019 isRetracted "false" @default.
- W1986677019 magId "1986677019" @default.
- W1986677019 workType "article" @default.